{"name":"Marker Therapeutics, Inc.","slug":"marker-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":11799154,"netIncome":-12163620,"cash":16068048,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-27","type":"pipeline","source":"simplywall.st","summary":"Exploring Three High Growth Tech Stocks In The US Market - simplywall.st","headline":"Exploring Three High Growth Tech Stocks In The US Market","sentiment":"neutral"},{"date":"2026-03-19","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOeGxQNHBtSVV0R2VYa0thcmlCTDBHNHRSRW9UX1F4bUh5VUV3bG9EdkNMa0E2Q1RCNU9nYkdwcTlJLW5KMVhONFI3QTVKVDlvcVR6bDhwLU54SXJSZGlRb3ZrNFYyMEJRaEdyRWsyb05oMGxqWE9PdmtwVjJzUEo2STZDMGY1WF8zNEk5NUlqSGw0ZS0xNll4LTNnNEJ4U2xPb3g0azl2SHBVYXdIQm5RR3dwZW1mWm41OXRUag?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"66% lymphoma response rate gives Marker a new data catalyst for 2026 - Stock Titan","headline":"66% lymphoma response rate gives Marker a new data catalyst for 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQSjBsNmt1MkZqWlBxd1JQRjAyRmo2LUZUVmRCQTZGVk9TSm5JM05GR2ZVUUZvS1F1OFdwa1pGNTkxcnEtbWpHVTVxd3VjelQ1cjJJUXAtMWY1NWVLR2dFT0pWallnajRReHVaQ3VtODRncnJPLUZBMzR5Yk9GZEllLTB6ZHllOFpKd3pxVWdPeHBkYWVNQ04zdXBFVzZrREJhTEhfZW10OENscVp5TFVUa3dhbXVGT0d2c0UtaGd3dWFzYmxzUkhkOW94UFNPaEt3aDE3T1kyZEVONzcyMnc?oc=5","date":"2026-03-18","type":"pipeline","source":"GlobeNewswire","summary":"Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results - GlobeNewswire","headline":"Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxONjFhckpwTlI1eElxTzJQYjdQRVhqLXk4ODhWMExrM1Y4dnNIMERZVS1NTmNmZkpRSkRFVTNBcGMtWURzZ2lpbHdCMDJCYmlDbHB2Zm5RZXV2N1NZcE9PSUN1RmgyTXk3V20tY1BLZS1CZGNrdEo5Zm1lWGRhSFRWTmNvaS1WSFY4dFg0Y2ZXYldQbVM1Mm1YZUhmLTN2eDFvYkl1YzVaMHp2blNlRkdLX1dR?oc=5","date":"2026-03-18","type":"pipeline","source":"Stock Titan","summary":"Marker Therapeutics (NASDAQ: MRKR) reports 2025 loss and cash runway into late 2026 - Stock Titan","headline":"Marker Therapeutics (NASDAQ: MRKR) reports 2025 loss and cash runway into late 2026","sentiment":"neutral"},{"date":"2026-03-18","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxPM0Zjam1LWTBHN1RlMHF2ajdHWEF4RXZTa1hhTVRzczJmZldERmprWWtFbkRFUkNyak92SHZqRU1ldWFITFM1RU1XcjBHajVLVzRaTU9ia0VLWmF6LXdLU1hyRXJmM1k0VjFDOERnWXAxdzVtMDFyS0FTalp5Q0J2VzhoQlAyZkk3bUxWM1l5clJNS1I5cHBvVV8yVDIwN252NnRwdE8xUzh6U0tkeHQyd3hZcGViZ0lvdDVQQzA1Mnd2a3lSUXVjaU05Mmc4VG5qalVmdmpiT2RvYk51eXR3ZkI5bEVhMXBteG1zdFF5OXdIMExrTHNuQ2FGSDhiQQ?oc=5","date":"2026-02-18","type":"pipeline","source":"GlobeNewswire","summary":"Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewswire","headline":"Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference","sentiment":"neutral"},{"date":"2026-02-09","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxPVVhRWlF5MjRyc2M5MnRxTHZjVE9iX0tSdDRVN1NxdmVPcWd5bnlaa2NISjY3UjVKS1NpMjhXbktxNUZKQWpQaHZoSUNtNEN1a2dqRTZUMGI0NTBqckdpU2dwQjlFY3I2eGJYR1BFWG1sQW1GeGxJWlZjdE9ZY1ROSDItZWhIVTM2YnJfUWF5ZDF1TGF2VnNMR2FnZVc2dkdwcUNMVy1ya0R4WXZ5WEVtM0FNQkF4SGR1czRUQzNTMjF0aVAtaGptaUowajlGanB5YnZpUVRLT2VGV2k3T1NrSVJJWFdLZlRHeWhUdHN1TTFTQU5EYjgzZVo1Tnh4MEkzQk9hMFdBanQzNDhlcDM3TmdXV0h6UWdGRlktV0plRVBVVFhfSE9RZFJINTk?oc=5","date":"2026-01-26","type":"pipeline","source":"GlobeNewswire","summary":"Good Morning America Features Baylor College of Medicine - GlobeNewswire","headline":"Good Morning America Features Baylor College of Medicine","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-12","type":"pipeline","source":"simplywall.st","summary":"Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation - simplywall.st","headline":"Here's Why We're Watching Marker Therapeutics' (NASDAQ:MRKR) Cash Burn Situation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQaHNyZWtjVnNRZzctdWE4VDVqNFRlR3oxSE05eGF0ZTB5aUFOTjhNYXc5VDJsUU9ib3NVZ2ozREpDWjhkUnpKZmhGQklhNXNGaUpUN0dwclFIY1kxS1l6bHRaaDh2Q3Q3ZmNtc2dJNnJoT1pIeGNGcVZ5U3BfMmV1VnBxeldPTnF0RWFQVXZuQQ?oc=5","date":"2026-01-08","type":"pipeline","source":"Yahoo Finance","summary":"Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance","headline":"Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceutic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxONGwtY0g4NW1qNVRtUjNZRmxETjJDUE11TTZpQkZfU1ZRWXl2X2lnSExrVFFsaVEzRUh1Z0k1SVoyeUhwd3h3N1NRQXZhdVVLdEdDMm44V3g1TGl6ZmZyX1QtamYzc1dTYjhOWnhqLW81YkJHbmtxNnB5RkIxQmFEcEM4N3lsZ1lpa2c?oc=5","date":"2025-12-18","type":"pipeline","source":"Yahoo Finance","summary":"Here's Why Marker Therapeutics (NASDAQ:MRKR) Must Use Its Cash Wisely - Yahoo Finance","headline":"Here's Why Marker Therapeutics (NASDAQ:MRKR) Must Use Its Cash Wisely","sentiment":"neutral"},{"date":"2025-11-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-11-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":0,"period":"2021-12-31"},{"value":500000,"period":"2020-12-31"},{"value":213194,"period":"2019-12-31"},{"value":205994,"period":"2018-12-31"},{"value":183064,"period":"2017-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":11799154,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-12163620,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":16068048,"cashHistory":[],"totalAssets":19070997,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}